Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

Guo and co-authors found no evidence of significant interaction in a subgroup analysis stratified by age, sex, race and ethnicity, obesity, insulin use, or molecular structure of GLP-1 agonist ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With the potential to significantly change consumer eating habits, they are ...

Since GLP-1 agonists soared in popularity thanks to their powerful ... Science History Institute invites monthly speakers who are leaders from a wide variety of chemical and life science companies to ...

The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...